TAUNA JEFFERY: Open Payments
NPI 1578162590 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 15 payments from 10 companies in 2025. Trend: 2023 $695 · 2024 $847 · 2025 $1,000
Food & beverage: $712Education: $288
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $230 |
| AstraZeneca Pharmaceuticals LP | 3 | $132 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $100 |
| SEAGEN INC. | 1 | $96 |
| Incyte Corporation | 1 | $91 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| GENZYME CORPORATION | 1 | $24 |
| PFIZER INC. | 1 | $21 |
Products named: RYBREVANT, OJJAARA, REBLOZYL, ICLUSIG, Jakafi, DARZALEX, IMFINZI, ENHERTU.
Industry payments across MT — which companies pay providers there.
